首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 以基因为基之药物开发

市场调查报告书

商品编码

1767706

Crispr 和 Cas 基因市场（按产品类型、应用、最终用户和地区划分）

Crispr and Cas Gene Market, By Product Type, By Application, By End User, By Geography

出版日期: 2025年06月02日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年 Crispr 和 Cas 基因市场规模为 23.2 亿美元，到 2032 年将达到 97.7 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 22.8%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	23.2亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年	22.80%	2032年价值预测	97.7亿美元

成簇规律间隔短回文重复序列 (CRISPR)-Cas9 是一项独特的技术，它允许遗传学家和医学研究人员透过移除、添加或改变部分去氧核糖核酸(DNA) 序列来编辑基因组。 CRISPR-Cas9 系统由两种主要分子组成，它们将突变引入 DNA。一种是名为 Cas9 的酵素。它就像一把“分子剪刀”，在基因组的特定位置切断 DNA 的两条链。第二种成分称为嚮导 RNA (gRNA)。它由一段预先设计的小 RNA 序列（约 20 个碱基长）组成，该序列位于一段较长的 RNA 支架内。此支架与 DNA 结合，预先设计的序列将 Cas9 「引导」至基因组的正确位置。这使得 Cas9 酶能够在基因组的正确位置进行切割。

市场动态

主要参与企业正在开发一系列利用 CRISPR 和 CAS 基因治疗遗传疾病的治疗方法。例如，2016 年，总部位于美国的 Addgene 公司开发了 KamiCas9，这是 CRISPR-Cas9 的一个版本，其中包含「自我惰性」的 KamiCas9 系统，用于编辑中枢神经系统 (CNS) 疾病基因，以治疗亨廷顿氏症。

CRISPR技术广泛应用于开发糖尿病、癌症等疾病的治疗方法。因此，预计此类疾病的日益普及将在预测期内推动市场成长。根据国际糖尿病联盟的数据，2019年全球约有4.63亿成年人（20-79岁）患有糖尿病，到2045年，这一数字将增加至7亿。此外，65岁以上族群中，五分之一患有糖尿病。

此外，根据世界卫生组织（WHO）的数据，截至2018年2月，癌症已成为全球第二大死因，全球新患者约1,810万例，死亡人数约960万例。根据该数据统计，约70%的癌症死亡发生在中低收入国家，全球约六分之一的死亡是由癌症引起的。

研究的主要特点

本报告对全球 CRISPR 和 CAS 基因市场进行了详细分析，并以 2024 年为基准年，对 2025 年至 2032 年期间的市场规模进行了预测。
它揭示了不同领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、区域前景以及主要企业采用的竞争策略的重要见解。
该报告根据公司概况、财务表现、产品系列、地理位置、分销策略、关键发展和策略以及未来计划等参数，概述了全球 CRISPR 和 CAS 基因市场的主要企业。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、技术改进、市场扩张和行销策略做出明智的决策。
全球 CRISPR 和 CAS 基因市场报告迎合了该行业的各个相关人员，例如投资者、供应商、製造商、经销商、新进业者和金融分析师。
相关人员可以透过 CRISPR 和 CAS 基因市场分析中使用的各种策略矩阵更轻鬆地做出决策。

介绍
北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 东南亚国协
- 澳洲
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
非洲
- 北非
- 中部非洲
- 南非

第八章竞争态势

公司简介
- Thermo Fisher Scientific Inc.
- Merck KGaA（Sigma-Aldrich）
- OriGene Technologies, Inc.
- New England Biolabs
- Cellecta, Inc.
- Agilent Technologies
- Applied StemCell, Inc.
- Synthego
- Genscript
- Mirus Bio LLC
- Integrated DNA Technologies, Inc.
- Mammoth Biosciences, Inc.

第九章章节

参考
调查方法

简介目录

Product Code: CMI2598

Crispr And Cas Gene Market is estimated to be valued at USD 2.32 Bn in 2025 and is expected to reach USD 9.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2.32 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	22.80%	2032 Value Projection:	USD 9.77 Bn

Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 is a unique technology that enables the geneticists and medical researchers to edit parts of the genome by removing, adding or altering sections of the deoxyribonucleic acids (DNA) sequence. The CRISPR-Cas9 system consists of two key molecules that introduce a mutation into the DNA. The first component is an enzyme, which is called as Cas9. This acts as a pair of 'molecular scissors' that can cut the two strands of DNA at a specific location in the genome so that bits of DNA can then be added or removed. The second component is called guide RNA (gRNA). This consists of a small piece of pre-designed RNA sequence (about 20 bases long) located within a longer RNA scaffold. The scaffold part binds to DNA and the pre-designed sequence 'guides' Cas9 to the right part of the genome. This makes sure that the Cas9 enzyme cuts at the right point in the genome.

Market Dynamics

Key players are developing various treatment options, such as CRISPR and CAS genes, for genetic diseases. For instance, in 2016, the U.S.-based company, Addgene, developed the KamiCas9, a version of CRISPR-Cas9 that includes a 'self-inactivating' KamiCas9 system for the editing of central nervous system (CNS) disease genes for the treatment of Huntington's disease.

CRISPR technology is widely used to develop therapeutics for diseases such as diabetes, cancer, etc. Hence, the increasing prevalence of such diseases is expected to drive the market growth over the forecast period. According to The International Diabetes Federation, in 2019, approximately 463 million adults (20-79 years of age) were living with diabetes; by 2045, this will increase to 700 million worldwide. Moreover, one in five of the people who are above 65 years old have diabetes.

Furthermore, according to data findings by the World Health Organization (WHO), in February 2018, cancer was the second-leading cause of death globally, and around 18.1 million new cases and 9.6 million deaths were registered due to cancer. According to the same source, around 70% of deaths from cancer occurred in low and middle income countries, and around one in six deaths across the globe were caused by cancer.

Key features of the study:

This report provides an in-depth analysis of global CRISPR and CAS gene market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global CRISPR and CAS gene market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global CRISPR and CAS gene market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the CRISPR and CAS gene market

Detailed Segmentation:

Global CRISPR and CAS Gene Market, By Product Type:
- Vector-based CAS
- DNA-free CAS
- Others
Global CRISPR and CAS Gene Market, By Application:
- Genome Engineering
- Disease Models
- Functional Genomics
- Knockdown/Activation
- Others
Global CRISPR and CAS Gene Market, By End User:
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
Global CRISPR and CAS Gene Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA (Sigma-Aldrich)
- OriGene Technologies, Inc.
- New England Biolabs
- Cellecta, Inc.
- Agilent Technologies, Inc.
- Applied StemCell, Inc.
- Synthego
- Genscript
- Mirus Bio LLC
- Integrated DNA Technologies, Inc.
- Mammoth Biosciences, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trends
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER's Analysis

4. Global Crispr And Cas Gene Market, By Product Type, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Vector-based Cas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
DNA-free Cas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

5. Global Crispr And Cas Gene Market, By Application, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Genome Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Disease Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Functional Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Knockdown/Activation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

6. Global Crispr And Cas Gene Market, By End User, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Academic & Government Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Crispr And Cas Gene Market, By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country/Region, 2020 -2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck KGaA (Sigma-Aldrich)
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- OriGene Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- New England Biolabs
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cellecta, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Agilent Technologies
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Applied StemCell, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Synthego
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Genscript
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mirus Bio LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Integrated DNA Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mammoth Biosciences, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
  - Analysts' Views

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

Crispr 和 Cas 基因市场（按产品类型、应用、最终用户和地区划分）

Crispr and Cas Gene Market, By Product Type, By Application, By End User, By Geography

市场动态